WO2023130514A1 - Coordination polymer nano material having combined photodynamic-starvation therapy function, preparation method therefor and application thereof - Google Patents

Coordination polymer nano material having combined photodynamic-starvation therapy function, preparation method therefor and application thereof Download PDF

Info

Publication number
WO2023130514A1
WO2023130514A1 PCT/CN2022/073661 CN2022073661W WO2023130514A1 WO 2023130514 A1 WO2023130514 A1 WO 2023130514A1 CN 2022073661 W CN2022073661 W CN 2022073661W WO 2023130514 A1 WO2023130514 A1 WO 2023130514A1
Authority
WO
WIPO (PCT)
Prior art keywords
coordination polymer
enzyme
photodynamic
starvation
preparation
Prior art date
Application number
PCT/CN2022/073661
Other languages
French (fr)
Chinese (zh)
Inventor
潘逸航
许宇智
曾乐立
Original Assignee
中山大学附属第七医院(深圳)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中山大学附属第七医院(深圳) filed Critical 中山大学附属第七医院(深圳)
Publication of WO2023130514A1 publication Critical patent/WO2023130514A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5146Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5192Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004Glucose oxidase (1.1.3.4)

Definitions

  • the invention belongs to the technical field of nanomaterials, and in particular relates to a coordination polymer nanomaterial with the function of photodynamic combined with starvation therapy and its preparation method and application.
  • Starvation therapy that relies on depleting intratumoral glucose represents an important antitumor therapeutic strategy.
  • glucose oxidase Glucose Oxidase
  • GOx glucose oxidase
  • other cell types e.g., immune cells, stem cells
  • glucose-consuming starvation therapeutic strategies often produce severe concurrent toxicity to normal cells. Therefore, it is very important to introduce the design concept of smart nanomaterials in the treatment mode to reduce systemic toxicity while consuming glucose in the tumor with high specificity, which is very important to improve the safety and efficacy of starvation treatment.
  • Coordination polymers are a class of functional materials that are connected by metal ions and organic ligands through coordination bonds. Due to the structure/function designability, high loading rate, and high biocompatibility of coordination polymers, they are widely used as nanocarriers in bioimaging, tumor therapy, and gene transfection, etc. However, in terms of starvation therapy, there are few types of coordination polymers to choose from, and most of them do not have tumor microenvironment responsiveness and therapeutic properties. It needs to be combined with other drug modifications to achieve the purpose of combined therapy, which increases the drug dose and the resulting damage. Security Question.
  • the present invention aims to solve at least one of the above-mentioned technical problems existing in the prior art. Therefore, the present invention provides a coordination polymer nanomaterial with photodynamic combined starvation therapeutic function.
  • the invention also provides a preparation method of the coordination polymer nanometer material with photodynamic combined starvation therapy function.
  • the invention also provides an antitumor drug.
  • the invention also provides an application of a coordination polymer nanometer material with photodynamic combined starvation therapy function.
  • the first aspect of the present invention provides a coordination polymer nanomaterial with photodynamic combined starvation therapy function
  • the coordination polymer material includes a carrier and an enzyme, the enzyme is loaded inside the carrier, the The enzyme is glucose oxidase or a simulated enzyme with glucose oxidase-like activity; the carrier is 1,2,4-triazole copper (I) complex.
  • the coordination polymer material provided by the present invention includes a carrier and an enzyme. Because the carrier 1,2,4-triazole copper (I) complex wraps the enzyme, the glucose in the blood cannot enter the interior of the material and the glucose oxidase (GOx) reaction, inhibiting the reaction between GOx and blood sugar, thereby reducing the systemic toxicity of GOx. Due to the high permeability and retention (EPR) effect of solid tumors, coordination polymer nanomaterials will accumulate in tumor tissues, and after being phagocytized by cancer cells, they will be released under the degradation of glutathione (GSH) highly expressed by cancer cells. Out load GOx. The released GOx catalyzes the oxidation reaction of glucose in cancer cells to form hydrogen peroxide. At the same time, the coordination polymer can catalyze the decomposition of hydrogen peroxide to produce OH under 808nm excitation, and finally achieve the specific effect of photodynamic combined starvation therapy on tumor cells.
  • EPR permeability and retention
  • the GOx in the coordination polymer nanomaterial of the present invention can be released specifically in tumor cells, can catalyze the oxidation of glucose in tumor cells, consume glucose and oxygen therein, and increase the levels of acidity, hypoxia and hydrogen peroxide , thereby blocking the energy supply of tumor cells and realizing starvation therapy.
  • the hydrogen peroxide produced by starvation therapy can become the raw material for the photodynamic reaction of the 1,2,4-triazole copper (I) complex, which enhances the effect of type I photodynamic therapy, and finally realizes efficient photodynamic combined with starvation treat.
  • This method has the following advantages:
  • the non-porous structure of the nanomaterial forms a protective barrier for starvation therapy, which can reduce the systemic toxicity of GOx without additional drug modification, so that it will not react with blood sugar to produce toxic hydrogen peroxide during the systemic circulation, Greatly increased the safety of starvation healing.
  • the nanomaterial exhibits excellent cancer cell targeting, can specifically release GOx in tumor cells, and perform tumor cell-specific photodynamic combined starvation therapy without causing toxicity to normal cells. Safe nanocarriers for starvation therapy.
  • the 1,2,4-triazole copper (I) complex is used as a cell delivery carrier for enzymes for starvation therapy, and as a photosensitizer itself for type I photodynamic therapy of hypoxia tolerance, without binding
  • Other drug modifications can achieve the purpose of combination therapy, reducing drug dosage and achieving efficient combination therapy.
  • the enzyme loading in the coordination polymer nanomaterial is 10-30%.
  • a second aspect of the present invention provides a method for preparing the coordination polymer nanomaterial, comprising the steps of:
  • the enzyme, Cu 2 O and 1,2,4-triazole are mixed and reacted, and the coordination polymer nanometer material is obtained through solid-liquid separation.
  • the coordination polymer nanometer material of the invention can be rapidly produced under mild conditions, ensures no loss of enzyme activity, is simple to prepare, easy to obtain raw materials, and is easy to realize large-scale industrial production.
  • the mass ratio of the enzyme, Cu 2 O and 1,2,4-triazole is 1:(4-8):(3-6).
  • the reaction time is 30-60 minutes.
  • the reducing agent comprises ascorbic acid or hydrazine hydrate.
  • the protective atmosphere includes nitrogen or argon.
  • the Cu 2 O is prepared by the following method: reacting a copper salt under the condition of a reducing agent and an inorganic base to generate Cu 2 O.
  • the inorganic base includes sodium hydroxide or potassium hydroxide.
  • the third aspect of the present invention provides an anti-tumor drug, which includes the above-mentioned coordination polymer nanomaterial having the function of photodynamic combined starvation therapy.
  • the fourth aspect of the present invention provides an application of a coordination polymer nanomaterial with photodynamic combined starvation therapy function in the preparation of antitumor drugs.
  • Fig. 1 is a schematic diagram of the principle of the present invention
  • Fig. 2 is the XRD figure of 1,2,4-triazole copper (I) complex
  • Fig. 3 is the result figure of protein electrophoresis
  • Fig. 4 is the infrared spectrogram of 1,2,4-triazole copper (I) complex, GOx and embodiment 1 coordination polymer;
  • Fig. 5 is the SEM figure of 1,2,4-triazole copper (I) complex and embodiment 1 coordination polymer
  • Fig. 6 is the enzymatic activity effect figure of GOx, embodiment 1 and comparative example 1 coordination polymer
  • Fig. 7 is the comparison diagram of the enzyme activity of the coordination polymer of embodiment 1 before and after ultrasonic;
  • Fig. 8 is the BET test figure of the coordination polymer of ZIF-8, comparative example 2, 1,2,4-triazole copper (I) complex and the coordination polymer of embodiment 1;
  • Fig. 9 is the toxicity data graph of 1,2,4-triazole copper (I) complex and Example 1 coordination polymer to MCF-7;
  • Figure 10 is a graph showing the toxicity data of GOx, the coordination polymers of Example 1 and Comparative Example 2 to cancer cells and normal cells;
  • Fig. 11 is the fluorescence value of APF after the coordination polymer of embodiment 1 is excited by hydrogen peroxide and 808nm;
  • Figure 12 is flow cytometry analysis of the cancer cell apoptosis rate of the coordination polymer in Example 1;
  • Fig. 13 is a graph showing the change of tumor volume over time in different treatment groups.
  • the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field unless otherwise specified.
  • human breast cancer cell MCF-7 and human bladder cancer cell 5637 were purchased from the Cell Resource Center of Shanghai Institute of Biological Sciences, Chinese Academy of Sciences.
  • Normal cells human normal breast epithelial cells MCF-10A were purchased from the Cell Resource Center of Shanghai Institute of Biological Sciences, Chinese Academy of Sciences.
  • mice Female BALB/C nude mice (6-8 weeks) were purchased from the Guangdong Provincial Medical Experimental Animal Center and used with the approval of the Animal Use and Care Committee of Sun Yat-sen University. All animal experiments were carried out in accordance with the National Regulations on the Care and Use of Laboratory Animals.
  • GOx@ZIF-8 nanoparticles First, dissolve 1.314g Hmim in 20mL of 50mM HEPES buffer, stir well to dissolve, then add 0.073g Zn(CH 3 COO) 2 to the mixed solution, stir at room temperature for half an hour, A milky white suspension was formed, and the product was collected by centrifugation at 12,000 rpm for 3 minutes, washed three times with ultrapure water, and then freeze-dried into powder to obtain ZIF-8 nanoparticles. Adding 10 mg GOx to the reaction solution can obtain GOx@ZIF-8 nanoparticles.
  • Embodiment 1 provides a kind of coordination polymer nanomaterial with photodynamic combined starvation therapy function
  • coordination polymer nanomaterial comprises 1,2,4-triazole copper (I) ([Cu (tz)]) and Enzyme, the enzyme is loaded inside the copper (I) 1,2,4-triazole.
  • the preparation method is as follows:
  • the product was collected by centrifugation at 12000rpm for 3 minutes, washed three times with ultrapure water, and then freeze-dried into a powder to obtain a coordination polymer nanomaterial (GOx@[Cu(tz)]).
  • the enzyme loading capacity was 20%.
  • Example 2 provides a coordination polymer nanomaterial with the function of photodynamic combined starvation therapy.
  • the preparation method and raw materials are the same as those in Example 1, the only difference being that the enzyme loading is 10%.
  • Example 3 provides a coordination polymer nanomaterial with the function of photodynamic combined starvation therapy.
  • the preparation method and raw materials are the same as those in Example 1, the only difference being that the enzyme loading is 30%.
  • Comparative Example 1 provides a coordination polymer nanomaterial, the preparation method is the same as that of Example 1, the difference is that 3,5-diethyl-1,2,4-triazole is used instead of 1,2,4 - Triazoles.
  • Comparative Example 1 provides a coordination polymer nanomaterial, the preparation method is the same as in Example 1, the difference is that the commonly used coordination polymer ZIF-8 is used to replace 1,2,4-triazole copper (I) Complexes.
  • Comparative Example 3 provides a coordination polymer nanomaterial, the raw material is the same as that of Example 1, the difference is that the enzyme is adsorbed on the surface of copper (I) 1,2,4-triazole.
  • the preparation method is as follows:
  • Fig. 1 is a schematic diagram of the principle of the present invention, including a schematic diagram of the preparation of coordination polymer nanomaterials and a schematic diagram of the principle of the coordination polymer nanomaterials for photodynamic combined starvation therapy of tumor cells.
  • the coordination polymer of comparative example 3 (swimming lane 3) and the coordination polymer sample (swimming lane 4) of embodiment 1 all can observe the band that has similar position with GOx (swimming lane 1), but the coordination of comparative example 3
  • the band of the position polymer is shallower than that of the coordination polymer of Example 1, this is because the GOx adsorbed on the surface is easily removed by cleaning, which is not conducive to practical application.
  • the in-situ package has a large loading capacity, is stable, and is not easy to leak, and GOx can only be released under the degradation of GSH.
  • the scanning electron microscope (SEM) image of Figure 5 shows that 1,2,4-triazole copper (I) is in the form of multi-rod aggregation, which tends to grow anisotropically.
  • the coordination polymer in Example 1 tends to grow isotropically and is spherical particles with uneven surface.
  • Dynamic light scattering (DLS) results show that the average particle diameters of 1,2,4-triazole copper (I) and the coordination polymer of Example 1 are about 200nm and 234nm respectively, indicating that the composite material after encapsulating the enzyme The particle size becomes larger.
  • Enzyme activity on glucose 0.15 ⁇ g GOx or 50 ⁇ g of the coordination polymer of Example 1 was added to 100 ⁇ L of PBS buffer ( 0.01 M, pH 7.4).
  • the real-time change of the absorbance at 415nm was detected with a multifunctional microplate reader, and the enzyme kinetic parameters were calculated by the Michaelis-Menten equation (Fig. 6).
  • the nitrogen adsorption data shows that ZIF-8, the coordination polymer of Comparative Example 2, 1,2,4-triazole copper (I) and the coordination polymer of Example 1 are respectively 1360, 888, 67.5 and 27.6m 2 g -1 , therefore, the coordination polymer of Comparative Example 2 is a porous material and cannot effectively protect enzymes, while the coordination polymer of the present invention has a non-porous structure.
  • the concentration of GSH in cancer cells is 3-10 times that of normal cells, and the coordination polymer nanomaterial in Example 1 has the performance of GSH responsive release, so cancer cell-specific starvation therapy can be realized.
  • the cytotoxicity of the coordination polymer nanomaterial in Example 1 to human breast cancer cell MCF-7 and human normal breast epithelial cell MCF-10A was determined by MTT method.
  • the coordination polymer nanomaterial of Example 1 has stronger cytotoxicity to cancer cell MCF-7, showing cancer cell-specific starvation therapeutic effect.
  • free GOx and the coordination polymer material of Comparative Example 2 have strong cytotoxicity to cancer cells and normal cells, and have no selectivity. And it cannot be applied, the results show that the coordination polymer nanomaterial of Example 1 can improve the selectivity and safety of starvation treatment.
  • APF fluorescein can selectively react with OH to generate fluorescence.
  • PBS solutions of coordination polymer nanomaterials with different concentrations in Example 1 were mixed with 1mM hydrogen peroxide and 0.8mM APF solution, and the solution was irradiated with 808nm laser (1W cm -1 ) for 10min.
  • the results in Figure 11 show that the fluorescence intensity of APF increases with the implementation
  • the concentration of the coordination polymer nanomaterial in Example 1 increases and increases, indicating that the coordination polymer nanomaterial in Example 1 can be used as a photosensitizer to generate active oxygen ⁇ OH.
  • Photodynamic combined starvation therapy for cancer cells Human bladder cancer cell line 5637 was divided into six groups, namely (a) control group (PBS), (b) light group (808nm excitation), (c) 1, 2,4-triazole copper (I), (d) single photodynamic therapy group (1,2,4-triazole copper (I)+808nm), (e) single starvation therapy group (embodiment 1) , (f) combined treatment group (embodiment 1+808nm).
  • the light conditions were 24 hours after tail vein injection of drugs, irradiated with 808nm laser (0.6W cm -1 ) for 20 minutes (irradiated twice, 10 minutes each time, 5 minutes apart).
  • Figure 13 shows the change of tumor volume over time in different treatment groups. The results showed that the monotherapy groups (c and d) were able to inhibit tumor growth, and the combination therapy group (e) was significantly better than the monotherapy groups (c and d) and the control group (a and b). The combined effect of tumor photodynamic and starvation therapy at the in vivo level was demonstrated.
  • Embodiment 2 and Embodiment 3 of the present invention have similar effects to Embodiment 1.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Medical Informatics (AREA)
  • Manufacturing & Machinery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A coordination polymer nano material having a combined photodynamic-starvation therapy function, a preparation method therefor and an application thereof. The coordination polymer nano material comprises a carrier and an enzyme. The enzyme is loaded in the carrier. The enzyme is glucose oxidase (GOx) or a mimic enzyme having a GOx-like activity. The carrier is a 1,2,4-triazole copper (I) complex. The GOx in the coordination polymer nano material can be specifically released in a tumor cell, and catalyze the oxidation of glucose in the tumor cell, consuming glucose and oxygen in the tumor cell, and improving the levels of acidity, low oxygen and hydrogen peroxide, thereby blocking the energy supply to the tumor cell, and achieving a starvation therapy. Meanwhile, hydrogen peroxide produced by the starvation therapy can also be used as a raw material for a photodynamic reaction of the 1,2,4-triazole copper (I) complex, thereby enhancing the type I photodynamic therapy effect, and finally achieving an efficient combined photodynamic-starvation therapy.

Description

一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料及其制备方法和应用A coordination polymer nanomaterial with photodynamic combined starvation therapy function and its preparation method and application 技术领域technical field
本发明属于纳米材料技术领域,尤其涉及一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料及其制备方法和应用。The invention belongs to the technical field of nanomaterials, and in particular relates to a coordination polymer nanomaterial with the function of photodynamic combined with starvation therapy and its preparation method and application.
背景技术Background technique
依靠消耗肿瘤内葡萄糖的饥饿治疗代表了一种重要的抗肿瘤治疗策略。其中作为一种生物催化剂,葡萄糖氧化酶(Glucose Oxidase;GOx)可以有效消耗肿瘤微环境中的葡萄糖和氧气,并提高酸性、低氧和过氧化氢的水平,从而阻断肿瘤细胞的能量供应,实现非侵袭的饥饿治疗。但由于其他类型细胞(如免疫细胞、干细胞)也进行有氧糖酵解,基于消耗葡萄糖的饥饿治疗策略经常对正常细胞产生严重的并发毒性。因此,在治疗模式中引入智能纳米材料的设计概念,在高特异性消耗肿瘤内葡萄糖的同时,降低系统毒性,对提高饥饿治疗的安全性和疗效十分重要。Starvation therapy that relies on depleting intratumoral glucose represents an important antitumor therapeutic strategy. Among them, as a biocatalyst, glucose oxidase (Glucose Oxidase; GOx) can effectively consume glucose and oxygen in the tumor microenvironment, and increase the level of acidity, hypoxia and hydrogen peroxide, thereby blocking the energy supply of tumor cells, Enables non-invasive starvation healing. But since other cell types (e.g., immune cells, stem cells) also undergo aerobic glycolysis, glucose-consuming starvation therapeutic strategies often produce severe concurrent toxicity to normal cells. Therefore, it is very important to introduce the design concept of smart nanomaterials in the treatment mode to reduce systemic toxicity while consuming glucose in the tumor with high specificity, which is very important to improve the safety and efficacy of starvation treatment.
配位聚合物是一类由金属离子与有机配体通过配位键连接而成的功能材料。由于配位聚合物的结构/功能可设计性、高负载率和高生物相容性,其作为纳米载体被广泛应用于生物成像、肿瘤治疗和基因转染等。但在饥饿治疗方面,可选择配位聚合物种类匮乏,并且多数不具有肿瘤微环境响应性以及治疗性,需要结合其他药物修饰才能达到联合治疗的目的,增大了药物剂量以及所带来的安全问题。Coordination polymers are a class of functional materials that are connected by metal ions and organic ligands through coordination bonds. Due to the structure/function designability, high loading rate, and high biocompatibility of coordination polymers, they are widely used as nanocarriers in bioimaging, tumor therapy, and gene transfection, etc. However, in terms of starvation therapy, there are few types of coordination polymers to choose from, and most of them do not have tumor microenvironment responsiveness and therapeutic properties. It needs to be combined with other drug modifications to achieve the purpose of combined therapy, which increases the drug dose and the resulting damage. Security Question.
因此有必要开发一种新的具有低毒性、肿瘤微环境响应性以及治疗性的配位聚合物纳米材料。Therefore, it is necessary to develop a new coordination polymer nanomaterial with low toxicity, tumor microenvironment responsiveness and therapeutic properties.
发明内容Contents of the invention
本发明旨在至少解决现有技术中存在的上述技术问题之一。为此,本发明提供了一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料。The present invention aims to solve at least one of the above-mentioned technical problems existing in the prior art. Therefore, the present invention provides a coordination polymer nanomaterial with photodynamic combined starvation therapeutic function.
本发明还提供了一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料的制备方法。The invention also provides a preparation method of the coordination polymer nanometer material with photodynamic combined starvation therapy function.
本发明还提供了一种抗肿瘤药物。The invention also provides an antitumor drug.
本发明还提供了一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料的应用。The invention also provides an application of a coordination polymer nanometer material with photodynamic combined starvation therapy function.
本发明的第一方面提供了一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料,所述配位聚合物材料包括载体和酶,所述酶负载在所述载体的内部,所述酶为葡萄糖氧化酶或者具有类葡萄糖氧化酶活性的模拟酶;所述载体为1,2,4-三氮唑铜(I)配合物。The first aspect of the present invention provides a coordination polymer nanomaterial with photodynamic combined starvation therapy function, the coordination polymer material includes a carrier and an enzyme, the enzyme is loaded inside the carrier, the The enzyme is glucose oxidase or a simulated enzyme with glucose oxidase-like activity; the carrier is 1,2,4-triazole copper (I) complex.
本发明提供的配位聚合物材料包括载体和酶,由于载体1,2,4-三氮唑铜(I)配合物将酶包裹,血液中的葡萄糖无法进入材料内部与负载的葡萄糖氧化酶(GOx)反应,抑制了GOx与血糖的反应从而降低了GOx的系统毒性。由于实体瘤的高通透性和滞留(EPR)效应,配位聚合物纳米材料会在肿瘤组织聚集,被癌细胞吞噬后,在癌细胞高表达的谷胱甘肽(GSH)降解下,释放出负载的GOx。释放的GOx催化癌细胞内的葡萄糖发生氧化反应形成过氧化氢,同时配位聚合物在808nm激发下可催化过氧化氢分解产生·OH,最终实现肿瘤细胞特异性的光动力联合饥饿治疗效果。The coordination polymer material provided by the present invention includes a carrier and an enzyme. Because the carrier 1,2,4-triazole copper (I) complex wraps the enzyme, the glucose in the blood cannot enter the interior of the material and the glucose oxidase ( GOx) reaction, inhibiting the reaction between GOx and blood sugar, thereby reducing the systemic toxicity of GOx. Due to the high permeability and retention (EPR) effect of solid tumors, coordination polymer nanomaterials will accumulate in tumor tissues, and after being phagocytized by cancer cells, they will be released under the degradation of glutathione (GSH) highly expressed by cancer cells. Out load GOx. The released GOx catalyzes the oxidation reaction of glucose in cancer cells to form hydrogen peroxide. At the same time, the coordination polymer can catalyze the decomposition of hydrogen peroxide to produce OH under 808nm excitation, and finally achieve the specific effect of photodynamic combined starvation therapy on tumor cells.
本发明关于配位聚合物纳米材料的技术方案中的一个技术方案,至少具有以下有益效果:One of the technical solutions of the present invention about coordination polymer nanomaterials has at least the following beneficial effects:
本发明的配位聚合物纳米材料中的GOx能够在肿瘤细胞中特异性释放出来,能催化肿瘤细胞中的葡萄糖氧化,消耗其中的葡萄糖及氧气,并提高酸性、低氧和过氧化氢的水平,从而阻断肿瘤细胞的能量供应,实现饥饿治疗。同时饥饿治疗产生的过氧化氢又可以成为1,2,4-三氮唑铜(I)配合物发生光动力反应的原料,增强了I型光动力治疗效果,最终实现高效的光动力联合饥饿治疗。该方法具有以下优点:The GOx in the coordination polymer nanomaterial of the present invention can be released specifically in tumor cells, can catalyze the oxidation of glucose in tumor cells, consume glucose and oxygen therein, and increase the levels of acidity, hypoxia and hydrogen peroxide , thereby blocking the energy supply of tumor cells and realizing starvation therapy. At the same time, the hydrogen peroxide produced by starvation therapy can become the raw material for the photodynamic reaction of the 1,2,4-triazole copper (I) complex, which enhances the effect of type I photodynamic therapy, and finally realizes efficient photodynamic combined with starvation treat. This method has the following advantages:
(1)该纳米材料无孔的结构形成了饥饿治疗的保护屏障,无需额外的药物修饰就能降低GOx的系统毒性,使之在体循环过程中不会与血糖反应而产生有毒的过氧化氢,大大提高了饥饿治疗的安全性。(1) The non-porous structure of the nanomaterial forms a protective barrier for starvation therapy, which can reduce the systemic toxicity of GOx without additional drug modification, so that it will not react with blood sugar to produce toxic hydrogen peroxide during the systemic circulation, Greatly increased the safety of starvation healing.
(2)该纳米材料表现出卓越的癌细胞靶向性,能特异性地在肿瘤细胞中释放GOx,进行肿瘤细胞特异性的光动力联合饥饿治疗,而不会对正常细胞产生毒害,有望作为饥饿治疗的安全纳米载体。(2) The nanomaterial exhibits excellent cancer cell targeting, can specifically release GOx in tumor cells, and perform tumor cell-specific photodynamic combined starvation therapy without causing toxicity to normal cells. Safe nanocarriers for starvation therapy.
(3)1,2,4-三氮唑铜(I)配合物即作为酶的细胞递送载体用于饥饿治疗,本身又作为光敏剂用于缺氧耐受性I型光动力治疗,无需结合其他药物修饰便能达到联合治疗的目的,减少药物剂量的同时实现高效的联合治疗。(3) The 1,2,4-triazole copper (I) complex is used as a cell delivery carrier for enzymes for starvation therapy, and as a photosensitizer itself for type I photodynamic therapy of hypoxia tolerance, without binding Other drug modifications can achieve the purpose of combination therapy, reducing drug dosage and achieving efficient combination therapy.
(4)联合饥饿治疗及I型光动力治疗,在细胞水平及动物水平上均展现出了高的抗肿瘤功效,表明该多功能纳米药物有希望作为饥饿治疗和光动力协同的治疗平台而用于癌症治疗中,具有良好的应用前景。(4) The combination of starvation therapy and type I photodynamic therapy showed high anti-tumor efficacy at the cellular level and animal level, indicating that this multifunctional nanomedicine is expected to be used as a therapeutic platform for starvation therapy and photodynamic synergy. In cancer treatment, it has a good application prospect.
根据本发明的一些实施方式,所述配位聚合物纳米材料中酶的负载量为10~30%。According to some embodiments of the present invention, the enzyme loading in the coordination polymer nanomaterial is 10-30%.
根据本发明的一些实施方式,所述1,2,4-三氮唑铜(I)属于单斜晶系、P-1空间群,晶胞参数为:
Figure PCTCN2022073661-appb-000001
α=79.648(4)°,β=79.043(3)°,γ=78.855(4)°。
According to some embodiments of the present invention, the 1,2,4-triazole copper (I) belongs to the monoclinic system and the P-1 space group, and the unit cell parameters are:
Figure PCTCN2022073661-appb-000001
α=79.648(4)°, β=79.043(3)°, γ=78.855(4)°.
本发明的第二方面提供所述配位聚合物纳米材料的制备方法,包括如下步骤:A second aspect of the present invention provides a method for preparing the coordination polymer nanomaterial, comprising the steps of:
将酶、Cu 2O与1,2,4-三氮唑混合进行反应,经过固液分离得到配位聚合物纳米材料。 The enzyme, Cu 2 O and 1,2,4-triazole are mixed and reacted, and the coordination polymer nanometer material is obtained through solid-liquid separation.
本发明的配位聚合物纳米材料能在温和的条件下快速生成,保证酶活性不会损失、制备简单、原料容易获得,易于实现大规模的工业化生产。The coordination polymer nanometer material of the invention can be rapidly produced under mild conditions, ensures no loss of enzyme activity, is simple to prepare, easy to obtain raw materials, and is easy to realize large-scale industrial production.
根据本发明的一些实施方式,所述酶、Cu 2O与1,2,4-三氮唑的质量比为1:(4~8):(3~6)。 According to some embodiments of the present invention, the mass ratio of the enzyme, Cu 2 O and 1,2,4-triazole is 1:(4-8):(3-6).
根据本发明的一些实施方式,所述反应的时间为30~60min。According to some embodiments of the present invention, the reaction time is 30-60 minutes.
根据本发明的一些实施方式,所述还原剂包括抗坏血酸或水合肼。According to some embodiments of the present invention, the reducing agent comprises ascorbic acid or hydrazine hydrate.
根据本发明的一些实施方式,所述保护气氛包括氮气或氩气。According to some embodiments of the present invention, the protective atmosphere includes nitrogen or argon.
根据本发明的一些实施方式,所述Cu 2O通过如下方法制备:将铜盐在还原剂和无机碱的条件下反应生成Cu 2O。 According to some embodiments of the present invention, the Cu 2 O is prepared by the following method: reacting a copper salt under the condition of a reducing agent and an inorganic base to generate Cu 2 O.
根据本发明的一些实施方式,所述无机碱包括氢氧化钠或氢氧化钾。According to some embodiments of the present invention, the inorganic base includes sodium hydroxide or potassium hydroxide.
本发明的第三方面提供一种抗肿瘤药物,所述抗肿瘤药物包括上述具有光动力联合饥饿治疗功能的配位聚合物纳米材料。The third aspect of the present invention provides an anti-tumor drug, which includes the above-mentioned coordination polymer nanomaterial having the function of photodynamic combined starvation therapy.
本发明的第四方面提供一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料在 制备抗肿瘤药物中的应用。The fourth aspect of the present invention provides an application of a coordination polymer nanomaterial with photodynamic combined starvation therapy function in the preparation of antitumor drugs.
附图说明Description of drawings
图1是本发明的原理示意图;Fig. 1 is a schematic diagram of the principle of the present invention;
图2是1,2,4-三氮唑铜(I)配合物XRD图;Fig. 2 is the XRD figure of 1,2,4-triazole copper (I) complex;
图3是蛋白质电泳结果图;Fig. 3 is the result figure of protein electrophoresis;
图4是1,2,4-三氮唑铜(I)配合物、GOx和实施例1配位聚合物的红外光谱图;Fig. 4 is the infrared spectrogram of 1,2,4-triazole copper (I) complex, GOx and embodiment 1 coordination polymer;
图5是1,2,4-三氮唑铜(I)配合物和实施例1配位聚合物的SEM图;Fig. 5 is the SEM figure of 1,2,4-triazole copper (I) complex and embodiment 1 coordination polymer;
图6是GOx、实施例1和对比例1配位聚合物的酶催化活性效果图;Fig. 6 is the enzymatic activity effect figure of GOx, embodiment 1 and comparative example 1 coordination polymer;
图7是实施例1配位聚合物在超声前后的酶活性对比图;Fig. 7 is the comparison diagram of the enzyme activity of the coordination polymer of embodiment 1 before and after ultrasonic;
图8是ZIF-8、对比例2的配位聚合物、1,2,4-三氮唑铜(I)配合物和实施例1的配位聚合物的BET测试图;Fig. 8 is the BET test figure of the coordination polymer of ZIF-8, comparative example 2, 1,2,4-triazole copper (I) complex and the coordination polymer of embodiment 1;
图9是1,2,4-三氮唑铜(I)配合物和实施例1配位聚合物对MCF-7的毒性数据图;Fig. 9 is the toxicity data graph of 1,2,4-triazole copper (I) complex and Example 1 coordination polymer to MCF-7;
图10是GOx、实施例1和对比例2的配位聚合物对癌细胞和正常细胞的毒性数据图;Figure 10 is a graph showing the toxicity data of GOx, the coordination polymers of Example 1 and Comparative Example 2 to cancer cells and normal cells;
图11是实施例1配位聚合物在过氧化氢和808nm激发后APF的荧光值;Fig. 11 is the fluorescence value of APF after the coordination polymer of embodiment 1 is excited by hydrogen peroxide and 808nm;
图12是流式细胞术分析实施例1配位聚合物的癌细胞凋亡率;Figure 12 is flow cytometry analysis of the cancer cell apoptosis rate of the coordination polymer in Example 1;
图13是不同治疗组肿瘤体积随时间变化数据图。Fig. 13 is a graph showing the change of tumor volume over time in different treatment groups.
具体实施方式Detailed ways
下面将对本发明实施例中的技术方案进行清楚、完整地描述,但本发明的实施方式不限于此。The technical solutions in the embodiments of the present invention will be clearly and completely described below, but the implementation manners of the present invention are not limited thereto.
本发明所采用的试剂、方法和设备,如无特殊说明,均为本技术领域常规试剂、方法和设备。The reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field unless otherwise specified.
以下实施例及对比例中采用的原料如下:The raw materials adopted in the following examples and comparative examples are as follows:
癌细胞:人乳腺癌细胞MCF-7和人膀胱癌细胞5637购自中科院上海生物科学研究 所细胞资源中心。Cancer cells: human breast cancer cell MCF-7 and human bladder cancer cell 5637 were purchased from the Cell Resource Center of Shanghai Institute of Biological Sciences, Chinese Academy of Sciences.
正常细胞:人正常乳腺上皮细胞MCF-10A购自中科院上海生物科学研究所细胞资源中心。Normal cells: human normal breast epithelial cells MCF-10A were purchased from the Cell Resource Center of Shanghai Institute of Biological Sciences, Chinese Academy of Sciences.
老鼠:雌性BALB/C裸鼠(6-8周)购于广东省医学实验动物中心,经中山大学动物使用与护理委员会批准使用。所有动物实验均按照国家《实验动物护理和使用条例》进行。Mice: Female BALB/C nude mice (6-8 weeks) were purchased from the Guangdong Provincial Medical Experimental Animal Center and used with the approval of the Animal Use and Care Committee of Sun Yat-sen University. All animal experiments were carried out in accordance with the National Regulations on the Care and Use of Laboratory Animals.
GOx@ZIF-8纳米颗粒:首先将1.314g Hmim溶于20mL的50mM HEPES缓冲液中,充分搅拌溶解,然后向混合溶液中加入0.073g Zn(CH 3COO) 2,室温搅拌反应半小后,形成乳白色悬浊液,以12000rpm离心3分钟收集产物,并用超纯水洗涤三次后冻干成粉末得到ZIF-8纳米颗粒。往反应液中加入10mg GOx,则可以得到GOx@ZIF-8纳米颗粒。 GOx@ZIF-8 nanoparticles: First, dissolve 1.314g Hmim in 20mL of 50mM HEPES buffer, stir well to dissolve, then add 0.073g Zn(CH 3 COO) 2 to the mixed solution, stir at room temperature for half an hour, A milky white suspension was formed, and the product was collected by centrifugation at 12,000 rpm for 3 minutes, washed three times with ultrapure water, and then freeze-dried into powder to obtain ZIF-8 nanoparticles. Adding 10 mg GOx to the reaction solution can obtain GOx@ZIF-8 nanoparticles.
实施例1Example 1
实施例1提供一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料,配位聚合物纳米材料包括1,2,4-三氮唑铜(I)([Cu(tz)])和酶,酶负载在1,2,4-三氮唑铜(I)的内部。制备方法如下: Embodiment 1 provides a kind of coordination polymer nanomaterial with photodynamic combined starvation therapy function, coordination polymer nanomaterial comprises 1,2,4-triazole copper (I) ([Cu (tz)]) and Enzyme, the enzyme is loaded inside the copper (I) 1,2,4-triazole. The preparation method is as follows:
室温下向含有0.2mmol Cu(NO 3) 2和0.6mmol抗坏血酸的10mL溶液中加入0.4g NaOH,迅速生成Cu 2O纳米颗粒,离心后洗涤。将生成的Cu 2O纳米颗粒溶解在1mL超纯水中。在氮气保护下,将该1mL Cu 2O溶液加入含有10mg GOx、4mmol 1,2,4-三氮唑和0.7mmol抗坏血酸的19mL水溶液中。室温下搅拌反应半小时后,以12000rpm离心3分钟收集产物,并用超纯水洗涤三次后冻干成粉末得到配位聚合物纳米材料(GOx@[Cu(tz)]),酶的负载量为20%。 Add 0.4 g NaOH to 10 mL solution containing 0.2 mmol Cu(NO 3 ) 2 and 0.6 mmol ascorbic acid at room temperature to rapidly generate Cu 2 O nanoparticles, which are washed after centrifugation. Dissolve the generated Cu2O nanoparticles in 1 mL of ultrapure water. Under nitrogen protection, this 1 mL Cu 2 O solution was added to 19 mL aqueous solution containing 10 mg GOx, 4 mmol 1,2,4-triazole and 0.7 mmol ascorbic acid. After stirring and reacting at room temperature for half an hour, the product was collected by centrifugation at 12000rpm for 3 minutes, washed three times with ultrapure water, and then freeze-dried into a powder to obtain a coordination polymer nanomaterial (GOx@[Cu(tz)]). The enzyme loading capacity was 20%.
实施例2Example 2
实施例2提供一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料,制备方法和原料同实施例1,其区别仅在于,酶的负载量为10%。Example 2 provides a coordination polymer nanomaterial with the function of photodynamic combined starvation therapy. The preparation method and raw materials are the same as those in Example 1, the only difference being that the enzyme loading is 10%.
实施例3Example 3
实施例3提供一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料,制备方法和原料同实施例1,其区别仅在于,酶的负载量为30%。Example 3 provides a coordination polymer nanomaterial with the function of photodynamic combined starvation therapy. The preparation method and raw materials are the same as those in Example 1, the only difference being that the enzyme loading is 30%.
对比例1Comparative example 1
对比例1提供了一种配位聚合物纳米材料,制备方法与实施例1相同,其区别在于,采用3,5-二乙基-1,2,4-三氮唑替代1,2,4-三氮唑。Comparative Example 1 provides a coordination polymer nanomaterial, the preparation method is the same as that of Example 1, the difference is that 3,5-diethyl-1,2,4-triazole is used instead of 1,2,4 - Triazoles.
对比例2Comparative example 2
对比例1提供了一种配位聚合物纳米材料,制备方法与实施例1相同,其区别在于,采用常用的配位聚合物ZIF-8替代1,2,4-三氮唑铜(I)配合物。Comparative Example 1 provides a coordination polymer nanomaterial, the preparation method is the same as in Example 1, the difference is that the commonly used coordination polymer ZIF-8 is used to replace 1,2,4-triazole copper (I) Complexes.
对比例3Comparative example 3
对比例3提供一种配位聚合物纳米材料,原料与实施例1相同,其区别在于,酶吸附在1,2,4-三氮唑铜(I)表面。制备方法如下:Comparative Example 3 provides a coordination polymer nanomaterial, the raw material is the same as that of Example 1, the difference is that the enzyme is adsorbed on the surface of copper (I) 1,2,4-triazole. The preparation method is as follows:
室温下向含有0.2mmol Cu(NO 3) 2和0.6mmol抗坏血酸的10mL溶液中加入0.4g NaOH,迅速生成Cu 2O纳米颗粒,离心后洗涤。将生成的Cu 2O纳米颗粒溶解在1mL超纯水中。在氮气保护下,该1mL Cu 2O溶液加入含有4mmol 1,2,4-三氮唑、0.7mmol抗坏血酸的19mL水溶液中。室温下搅拌反应1小时,待溶液变白后,在氮气保护下加入10mg GOx,混合半小时后,以12000rpm离心3分钟收集产物,并用超纯水洗涤三次后冻干成粉末备用。 Add 0.4 g NaOH to 10 mL solution containing 0.2 mmol Cu(NO 3 ) 2 and 0.6 mmol ascorbic acid at room temperature to rapidly generate Cu 2 O nanoparticles, which are washed after centrifugation. Dissolve the generated Cu2O nanoparticles in 1 mL of ultrapure water. Under nitrogen protection, this 1 mL Cu 2 O solution was added to 19 mL aqueous solution containing 4 mmol 1,2,4-triazole and 0.7 mmol ascorbic acid. The reaction was stirred at room temperature for 1 hour. After the solution turned white, 10 mg GOx was added under nitrogen protection. After mixing for half an hour, the product was collected by centrifugation at 12,000 rpm for 3 minutes, washed with ultrapure water three times, and freeze-dried into a powder for later use.
性能测试Performance Testing
图1是本发明的原理示意图,包括了配位聚合物纳米材料的制备示意图以及配位聚合物纳米材料实现光动力联合饥饿治疗肿瘤细胞的原理示意图。Fig. 1 is a schematic diagram of the principle of the present invention, including a schematic diagram of the preparation of coordination polymer nanomaterials and a schematic diagram of the principle of the coordination polymer nanomaterials for photodynamic combined starvation therapy of tumor cells.
1.对1,2,4-三氮唑铜(I)配合物进行X射线衍射(XRD),如图2所示,1,2,4-三氮唑铜(I)配合物属于单斜晶系、P-1空间群,晶胞参数为:
Figure PCTCN2022073661-appb-000002
Figure PCTCN2022073661-appb-000003
α=79.648(4)°,β=79.043(3)°,γ=78.855(4)°。
1. Carry out X-ray diffraction (XRD) on 1,2,4-triazole copper (I) complex, as shown in Figure 2, 1,2,4-triazole copper (I) complex belongs to monoclinic Crystal system, P-1 space group, unit cell parameters are:
Figure PCTCN2022073661-appb-000002
Figure PCTCN2022073661-appb-000003
α=79.648(4)°, β=79.043(3)°, γ=78.855(4)°.
2.对1,2,4-三氮唑铜(I)、实施例1的配位聚合物和对比例3的配位聚合物进行蛋白质电泳试验:2. Carry out protein electrophoresis test to 1,2,4-triazole copper (I), the coordination polymer of embodiment 1 and the coordination polymer of comparative example 3:
将5mg 1,2,4-三氮唑铜(I),对比例3的配位聚合物或实施例1的配位聚合物与10mM GSH反应一小时,降解材料,使GOx释放到溶液中。通过蛋白质电泳检测上清液的GOx分子。如图3所示,无包酶的1,2,4-三氮唑铜(I)(泳道2)没有任何蛋白质条带。而对比例3的配位聚合物(泳道3)及实施例1的配位聚合物样品(泳道4)均可以观察到与GOx(泳道1)具有相似位置的条带,但对比例3的配位聚合物较实施例1的配位聚合物的条带浅,这是因为表面吸附的GOx容易被清洗除去,不利于实际应用。而原位包裹的负载量大,并且稳定,不容易渗漏,只有在GSH的降解下才能释放出GOx。5 mg of 1,2,4-triazole copper(I), the coordination polymer of Comparative Example 3 or the coordination polymer of Example 1 were reacted with 10 mM GSH for one hour to degrade the material and release GOx into the solution. GOx molecules in the supernatant were detected by protein electrophoresis. As shown in Figure 3, the 1,2,4-triazole copper (I) without enzyme (lane 2) did not have any protein bands. And the coordination polymer of comparative example 3 (swimming lane 3) and the coordination polymer sample (swimming lane 4) of embodiment 1 all can observe the band that has similar position with GOx (swimming lane 1), but the coordination of comparative example 3 The band of the position polymer is shallower than that of the coordination polymer of Example 1, this is because the GOx adsorbed on the surface is easily removed by cleaning, which is not conducive to practical application. On the other hand, the in-situ package has a large loading capacity, is stable, and is not easy to leak, and GOx can only be released under the degradation of GSH.
3.对1,2,4-三氮唑铜(I)、实施例1的配位聚合物和葡萄糖氧化酶进行红外光谱试验:3. 1,2,4-triazole copper (I), the coordination polymer of embodiment 1 and glucose oxidase are carried out infrared spectrum test:
从图4看,GOx和实施例1的配位聚合物在1640~1660cm -1处均有特征峰,对应的是蛋白质酰胺I伸缩振动(主要来自C=O伸缩),而在1,2,4-三氮唑铜(I)样品中则无此伸缩振动,进一步验证了实施例1的配位聚合物中GOx的存在。 From Figure 4, both GOx and the coordination polymer of Example 1 have characteristic peaks at 1640-1660 cm- 1 , corresponding to protein amide I stretching vibration (mainly from C=O stretching), while at 1, 2, There is no such stretching vibration in the 4-triazole copper (I) sample, which further verifies the existence of GOx in the coordination polymer of Example 1.
4.对1,2,4-三氮唑铜(I)、实施例1的配位聚合物进行扫描电子显微镜试验:4. The coordination polymer of 1,2,4-triazole copper (I), embodiment 1 is carried out scanning electron microscopy test:
图5的扫描电子显微镜(SEM)图显示1,2,4-三氮唑铜(I)呈多棒状聚集的形态,趋向于各向异性生长。而实施例1的配位聚合物则偏向于各向同性生长,呈表面凹凸不平的球状颗粒。动态光散射(DLS)结果显示,1,2,4-三氮唑铜(I)及实施例1的配位聚合物的平均粒径约分别为200nm和234nm,说明包裹了酶之后的复合材料粒径变大。The scanning electron microscope (SEM) image of Figure 5 shows that 1,2,4-triazole copper (I) is in the form of multi-rod aggregation, which tends to grow anisotropically. However, the coordination polymer in Example 1 tends to grow isotropically and is spherical particles with uneven surface. Dynamic light scattering (DLS) results show that the average particle diameters of 1,2,4-triazole copper (I) and the coordination polymer of Example 1 are about 200nm and 234nm respectively, indicating that the composite material after encapsulating the enzyme The particle size becomes larger.
5.将GOx、实施例1的配位聚合物纳米材料和对比例1的配位聚合物纳米对酶活性测试:5. GOx, the coordination polymer nanomaterial of embodiment 1 and the coordination polymer nanometer of comparative example 1 are tested for enzyme activity:
对葡萄糖的酶活性:将0.15μg GOx或50μg实施例1的配位聚合物加入含有0.05mg mL -1HRP,274μg mL -1ABTS及不同浓度葡萄糖(0~300mM)的100μL PBS缓冲液(0.01M,pH 7.4)中。用多功能酶标仪检测415nm吸光度的实时变化,通过米氏方程计算酶动力学参数(图6)。得到的实施例1的配位聚合物纳米材料的催化活性仅为GOx的1/10000~1/1000,实施例1的配位聚合物的酶催化活性(k cat/K m=0.051s -1mM -1)。这是因为1,2,4-三氮唑铜(I)无孔结构的特性,阻碍了GOx与葡萄糖底物的接触与反应,能够有效抑制GOx的活性。而当1,2,4-三氮唑铜(I)结构被破坏(这里用超声降解),GOx的酶活性才会恢复(图7)。 Enzyme activity on glucose: 0.15 μg GOx or 50 μg of the coordination polymer of Example 1 was added to 100 μL of PBS buffer ( 0.01 M, pH 7.4). The real-time change of the absorbance at 415nm was detected with a multifunctional microplate reader, and the enzyme kinetic parameters were calculated by the Michaelis-Menten equation (Fig. 6). The catalytic activity of the coordination polymer nanomaterial obtained in Example 1 is only 1/10000~1/1000 of GOx, and the enzyme catalytic activity of the coordination polymer in Example 1 (k cat /K m =0.051s -1 mM −1 ). This is because the non-porous structure of 1,2,4-triazole copper (I) hinders the contact and reaction between GOx and glucose substrate, which can effectively inhibit the activity of GOx. However, when the 1,2,4-triazole copper(I) structure was destroyed (sonication was used here), the enzymatic activity of GOx was restored (Fig. 7).
而对比例1的配位聚合物的酶催化活性(k cat/K m=240s -1mM -1)很高,接近于游离的GOx酶催化活性(420s -1mM -1)。这是因为对比例1的配位聚合物为多孔材料,不具备抑制葡萄糖氧化酶活性的能力。 However, the catalytic activity of the coordination polymer in Comparative Example 1 (k cat /K m =240s -1 mM -1 ) was very high, which was close to that of free GOx (420s -1 mM -1 ). This is because the coordination polymer in Comparative Example 1 is a porous material and does not have the ability to inhibit the activity of glucose oxidase.
6.对ZIF-8、对比例2的配位聚合物、1,2,4-三氮唑铜(I)和实施例1的配位聚合物进行BET测试:6. The coordination polymer of ZIF-8, comparative example 2, 1,2,4-triazole copper (I) and the coordination polymer of embodiment 1 carry out BET test:
如图8所示,氮气吸附数据显示,ZIF-8、对比例2的配位聚合物、1,2,4-三氮唑铜(I)和实施例1的配位聚合物分别为1360、888、67.5和27.6m 2g -1,因此,对比例2的配位聚合物的是多孔材料,不能有效保护酶,而本发明的配位聚合物为无孔结构。 As shown in Figure 8, the nitrogen adsorption data shows that ZIF-8, the coordination polymer of Comparative Example 2, 1,2,4-triazole copper (I) and the coordination polymer of Example 1 are respectively 1360, 888, 67.5 and 27.6m 2 g -1 , therefore, the coordination polymer of Comparative Example 2 is a porous material and cannot effectively protect enzymes, while the coordination polymer of the present invention has a non-porous structure.
7.通过MTT法测定1,2,4-三氮唑铜(I)及实施例1的配位聚合物纳米材料对人乳腺癌细胞MCF-7的细胞毒性。7. The cytotoxicity of 1,2,4-triazole copper (I) and the coordination polymer nanomaterial of Example 1 to human breast cancer cell MCF-7 was determined by MTT method.
如图9所示,1,2,4-三氮唑铜(I)在10~100μg mL -1浓度范围内孵育24h后,细胞存活率在80%以上,而40μg mL -1实施例1的配位聚合物纳米材料的细胞毒性大于75%。结果表明负载有GOx的复合材料显示出高的细胞毒性,具有饥饿治疗的效果。 As shown in Figure 9, after 24 hours of incubation with 1,2,4-triazole copper (I) in the concentration range of 10-100 μg mL -1 , the cell survival rate was above 80%, while 40 μg mL -1 of Example 1 The cytotoxicity of coordination polymer nanomaterials is greater than 75%. The results indicated that the composites loaded with GOx showed high cytotoxicity, which has the effect of starvation therapy.
8.测试实施例1的配位聚合物纳米材料和对比例2的配位聚合物纳米材料肿瘤细胞特异性:8. Test the coordination polymer nanomaterial of Example 1 and the coordination polymer nanomaterial of Comparative Example 2 for tumor cell specificity:
文献报道癌细胞中的GSH浓度是正常细胞的3~10倍,而实施例1的配位聚合物纳米材料具有GSH响应性释放的性能,因此可以实现癌细胞特异性的饥饿治疗。通过MTT法测定实施例1的配位聚合物纳米材料对人乳腺癌细胞MCF-7及人正常乳腺上皮细胞MCF-10A的细胞毒性。如图10所示,实施例1的配位聚合物纳米材料对癌细胞MCF-7具有更强的细胞毒性,显示出癌细胞特异性的饥饿治疗效果。而游离的GOx和对比例2的配位聚合物材料对癌细胞和正常细胞均有很强的细胞毒性,不具备选择性。且不能应用,结果表明实施例1的配位聚合物纳米材料可以提高饥饿治疗的选择性和安全性。It is reported in the literature that the concentration of GSH in cancer cells is 3-10 times that of normal cells, and the coordination polymer nanomaterial in Example 1 has the performance of GSH responsive release, so cancer cell-specific starvation therapy can be realized. The cytotoxicity of the coordination polymer nanomaterial in Example 1 to human breast cancer cell MCF-7 and human normal breast epithelial cell MCF-10A was determined by MTT method. As shown in FIG. 10 , the coordination polymer nanomaterial of Example 1 has stronger cytotoxicity to cancer cell MCF-7, showing cancer cell-specific starvation therapeutic effect. However, free GOx and the coordination polymer material of Comparative Example 2 have strong cytotoxicity to cancer cells and normal cells, and have no selectivity. And it cannot be applied, the results show that the coordination polymer nanomaterial of Example 1 can improve the selectivity and safety of starvation treatment.
9.检测实施例1的配位聚合物纳米材料是否具有光敏性:9. Detect whether the coordination polymer nanomaterial of embodiment 1 has photosensitivity:
APF荧光素可以选择性与·OH反应而产生荧光。不同浓度实施例1的配位聚合物纳米材料的PBS溶液与1mM过氧化氢及0.8mM APF溶液混合,溶液用808nm激光(1W cm -1)照射10min,图11结果显示,APF荧光强度随实施例1的配位聚合物纳米材 料的浓度上升而增强,表明实施例1的配位聚合物纳米材料可作为光敏剂而产生活性氧·OH。 APF fluorescein can selectively react with OH to generate fluorescence. PBS solutions of coordination polymer nanomaterials with different concentrations in Example 1 were mixed with 1mM hydrogen peroxide and 0.8mM APF solution, and the solution was irradiated with 808nm laser (1W cm -1 ) for 10min. The results in Figure 11 show that the fluorescence intensity of APF increases with the implementation The concentration of the coordination polymer nanomaterial in Example 1 increases and increases, indicating that the coordination polymer nanomaterial in Example 1 can be used as a photosensitizer to generate active oxygen·OH.
实验例1Experimental example 1
(1)对癌细胞的光动力联合饥饿治疗:将人膀胱癌细胞5637分为六组,分别为(a)对照组(PBS),(b)光照组(808nm激发),(c)1,2,4-三氮唑铜(I),(d)单一光动力治疗组(1,2,4-三氮唑铜(I)+808nm),(e)单一饥饿治疗组(实施例1),(f)联合治疗组(实施例1+808nm)。对于联合治疗组,将5637细胞与50μg mL -1实施例1的配位聚合物孵育4小时后,用808nm激光(0.6W cm -1)照射20min(照射两次,一次10min,中间间隔5min),随后放于培养箱继续培养20小时,培养结束后,用流式细胞术检测凋亡和坏死的5637细胞。处于早期凋亡的细胞仅被FITC染色(Q3),处于晚期的细胞凋亡或坏死细胞会被FITC和PI同时染色(Q2)。细胞凋亡率(Q2+Q3)结果如图12所示,六组的细胞凋亡率分别为11.21%,11.11%,14.28%,17.32%,27.98%和71.69%,结果表明联合治疗组相比于单一治疗组(d和e)存在增强效应,证明了肿瘤光动力与饥饿联合治疗的效果。 (1) Photodynamic combined starvation therapy for cancer cells: Human bladder cancer cell line 5637 was divided into six groups, namely (a) control group (PBS), (b) light group (808nm excitation), (c) 1, 2,4-triazole copper (I), (d) single photodynamic therapy group (1,2,4-triazole copper (I)+808nm), (e) single starvation therapy group (embodiment 1) , (f) combined treatment group (embodiment 1+808nm). For the combined treatment group, after incubating 5637 cells with 50 μg mL -1 of the coordination polymer of Example 1 for 4 hours, they were irradiated with 808nm laser (0.6W cm -1 ) for 20 minutes (two irradiations, 10 minutes each time, with an interval of 5 minutes in between) , and then placed in an incubator to continue culturing for 20 hours. After the culture was over, flow cytometry was used to detect the apoptosis and necrosis of 5637 cells. Early apoptotic cells were only stained by FITC (Q3), and late apoptotic or necrotic cells were stained by both FITC and PI (Q2). Apoptotic rate (Q2+Q3) result is shown in Figure 12, and the apoptotic rate of six groups is respectively 11.21%, 11.11%, 14.28%, 17.32%, 27.98% and 71.69%, and the result shows that combined treatment group compares There is a potentiation effect in the monotherapy groups (d and e), demonstrating the efficacy of combined photodynamic and starvation therapy in tumors.
(2)对荷瘤小鼠的光动力联合饥饿治疗:在雌性无胸腺裸鼠(六周)后腿皮下注射1×10 7 5637细胞悬液,构建荷5637瘤的裸鼠模型,分为五组,分别为(a)PBS,(b)1,2,4-三氮唑铜(I),(c)单一光动力治疗组(1,2,4-三氮唑铜(I)+808nm),(d)单一饥饿治疗组(实施例1),(e)联合治疗组(实施例1+808nm)。当肿瘤体积达100mm 3时,进行治疗实验。纳米材料的浓度为10mg kg -1。光照条件为尾静脉注射药物24小时后用808nm激光(0.6W cm -1)照射20min(照射两次,一次10min,中间间隔5min)。图13表示不同治疗组肿瘤体积随时间的变化情况。结果显示,单一治疗组(c和d)能够抑制肿瘤的生长,联合治疗组(e)的效果显著优于单一治疗组(c和d)以及对照组(a和b)。证明了活体水平的肿瘤光动力与饥饿联合治疗的效果。 (2) Photodynamic combined with starvation therapy for tumor-bearing mice: 1×10 7 5637 cell suspension was subcutaneously injected into the hind legs of female athymic nude mice (six weeks) to construct a 5637 tumor-bearing nude mouse model, which was divided into five groups. Groups, respectively (a) PBS, (b) 1,2,4-triazole copper (I), (c) single photodynamic therapy group (1,2,4-triazole copper (I)+808nm ), (d) single starvation treatment group (Example 1), (e) combined treatment group (Example 1+808nm). Treatment experiments were performed when the tumor volume reached 100 mm 3 . The concentration of nanomaterials is 10 mg kg -1 . The light conditions were 24 hours after tail vein injection of drugs, irradiated with 808nm laser (0.6W cm -1 ) for 20 minutes (irradiated twice, 10 minutes each time, 5 minutes apart). Figure 13 shows the change of tumor volume over time in different treatment groups. The results showed that the monotherapy groups (c and d) were able to inhibit tumor growth, and the combination therapy group (e) was significantly better than the monotherapy groups (c and d) and the control group (a and b). The combined effect of tumor photodynamic and starvation therapy at the in vivo level was demonstrated.
本发明的实施例2和实施例3具有实施例1相似的效果。 Embodiment 2 and Embodiment 3 of the present invention have similar effects to Embodiment 1.
显然,本发明的上述实施例仅仅是为清楚地说明本发明所作的举例,而并非是对本发明的实施方式的限定。对于所属领域的普通技术人员来说,在上述说明的基础上还可 以做出其它不同形式的变化或变动。这里无需也无法对所有的实施方式予以穷举。凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明权利要求的保护范围之内。Apparently, the above-mentioned embodiments of the present invention are only examples for clearly illustrating the present invention, rather than limiting the implementation of the present invention. For those of ordinary skill in the art, on the basis of the above description, other changes or changes in different forms can also be made. It is not necessary and impossible to exhaustively list all the implementation manners here. All modifications, equivalent replacements and improvements made within the spirit and principles of the present invention shall be included within the protection scope of the claims of the present invention.

Claims (10)

  1. 一种具有光动力联合饥饿治疗功能的配位聚合物纳米材料,其特征在于,所述配位聚合物纳米材料包括载体和酶,所述酶负载在所述载体的内部,所述酶为葡萄糖氧化酶或者具有类葡萄糖氧化酶活性的模拟酶;所述载体为1,2,4-三氮唑铜(I)配合物。A coordination polymer nanomaterial with photodynamic combined starvation therapy function, characterized in that the coordination polymer nanomaterial includes a carrier and an enzyme, the enzyme is loaded inside the carrier, and the enzyme is glucose Oxidase or mimic enzyme with glucose oxidase-like activity; the carrier is 1,2,4-triazole copper (I) complex.
  2. 根据权利要求1所述具有光动力联合饥饿治疗功能的配位聚合物纳米材料,其特征在于,所述配位聚合物纳米材料中酶的负载量为10~30%。The coordination polymer nanomaterial with photodynamic combined starvation therapy function according to claim 1, characterized in that the enzyme loading in the coordination polymer nanomaterial is 10-30%.
  3. 根据权利要求1所述具有光动力联合饥饿治疗功能的配位聚合物纳米材料,其特征在于,所述1,2,4-三氮唑铜(I)配合物属于单斜晶系、P-1空间群,晶胞参数为:
    Figure PCTCN2022073661-appb-100001
    Figure PCTCN2022073661-appb-100002
    α=79.648(4)°,β=79.043(3)°,γ=78.855(4)°。
    The coordination polymer nanomaterial with photodynamic combined starvation therapy function according to claim 1, characterized in that, the 1,2,4-triazole copper (I) complex belongs to the monoclinic crystal system, P- 1 space group, the unit cell parameters are:
    Figure PCTCN2022073661-appb-100001
    Figure PCTCN2022073661-appb-100002
    α=79.648(4)°, β=79.043(3)°, γ=78.855(4)°.
  4. 根据权利要求1~3任一项所述具有光动力联合饥饿治疗功能的配位聚合物纳米材料的制备方法,其特征在于,包括如下步骤:According to any one of claims 1 to 3, the preparation method of the coordination polymer nanomaterial with photodynamic combined starvation therapy function, is characterized in that it comprises the following steps:
    在保护气氛和还原剂下,将酶、Cu 2O与1,2,4-三氮唑混合进行反应,经过固液分离得到配位聚合物纳米材料。 Under a protective atmosphere and a reducing agent, the enzyme, Cu 2 O and 1,2,4-triazole are mixed and reacted, and the coordination polymer nanomaterial is obtained through solid-liquid separation.
  5. 根据权利要求4所述具有光动力联合饥饿治疗功能的配位聚合物纳米材料的制备方法,其特征在于,所述酶、Cu 2O与1,2,4-三氮唑的质量比为1:(4~8):(3~6)。 According to claim 4, the preparation method of the coordination polymer nanomaterial having photodynamic combined starvation therapy function, is characterized in that, the mass ratio of the enzyme, Cu2O and 1,2,4-triazole is 1 : (4~8): (3~6).
  6. 根据权利要求4所述具有光动力联合饥饿治疗功能的配位聚合物纳米材料的制备方法,其特征在于,所述反应的时间为30~60min。According to the preparation method of the coordination polymer nanomaterial with photodynamic combined starvation therapy function according to claim 4, it is characterized in that the reaction time is 30-60 minutes.
  7. 根据权利要求4所述具有光动力联合饥饿治疗功能的配位聚合物纳米材料的制备方法,其特征在于,所述还原剂包括抗坏血酸或水合肼。According to the preparation method of the coordination polymer nanomaterial with photodynamic combined starvation therapy function according to claim 4, it is characterized in that the reducing agent comprises ascorbic acid or hydrazine hydrate.
  8. 根据权利要求4所述具有光动力联合饥饿治疗功能的配位聚合物纳米材料的制备方法,其特征在于,所述保护气氛包括氮气或氩气。According to the preparation method of the coordination polymer nanomaterial with photodynamic combined starvation therapy function according to claim 4, it is characterized in that the protective atmosphere includes nitrogen or argon.
  9. 一种抗肿瘤药物,其特征在于,所述抗肿瘤药物包括权利要求1~3任一项所述具有光动力联合饥饿治疗功能的配位聚合物纳米材料。An anti-tumor drug, characterized in that the anti-tumor drug comprises the coordination polymer nanomaterial having the function of photodynamic combined starvation therapy according to any one of claims 1-3.
  10. 根据权利要求1~3任一项所述具有光动力联合饥饿治疗功能的配位聚合物纳米 材料在制备抗肿瘤药物中的应用。According to any one of claims 1 to 3, the application of the coordination polymer nanomaterial with photodynamic combined starvation therapy function in the preparation of antitumor drugs.
PCT/CN2022/073661 2022-01-04 2022-01-25 Coordination polymer nano material having combined photodynamic-starvation therapy function, preparation method therefor and application thereof WO2023130514A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202210003005.4 2022-01-04
CN202210003005.4A CN114452385A (en) 2022-01-04 2022-01-04 Coordination polymer nano material with photodynamic combined hunger therapy function and preparation method and application thereof

Publications (1)

Publication Number Publication Date
WO2023130514A1 true WO2023130514A1 (en) 2023-07-13

Family

ID=81408336

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/073661 WO2023130514A1 (en) 2022-01-04 2022-01-25 Coordination polymer nano material having combined photodynamic-starvation therapy function, preparation method therefor and application thereof

Country Status (2)

Country Link
CN (2) CN114452385A (en)
WO (1) WO2023130514A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109030802A (en) * 2018-06-08 2018-12-18 中山大学 A kind of integration granular pattern immobilised enzymes biosensor and its preparation method and application
CN109078176A (en) * 2018-08-14 2018-12-25 武汉大学 The nano material and the preparation method and application thereof of tumor cell membrane cladding
CN111253581A (en) * 2020-01-19 2020-06-09 浙江大学 Metal organic framework material for enhancing combination of chemical power therapy and hunger therapy, preparation method and application
CN111450270A (en) * 2020-04-24 2020-07-28 西南大学 Construction and application of catalytic nanoparticles based on glucose oxidase/iron phosphate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2304276B1 (en) * 2005-12-23 2009-07-28 Universidad Autonoma De Madrid Uam SYNERGIC EFFECT BETWEEN A CYANOGENIC SYSTEM AND ANOTHER OXIDATIVE INDUCTOR FOR TUMOR TREATMENT.
CN102503960B (en) * 2011-02-22 2015-11-18 中国科学院福建物质结构研究所 High-efficiency fluorescence crystalline material of a kind of novel triazole copper complex and preparation method thereof
CN106397785A (en) * 2016-09-12 2017-02-15 广西师范大学 3-carboxyl-1, 2, 4-triazole copper coordination polymer and in-situ synthesis method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109030802A (en) * 2018-06-08 2018-12-18 中山大学 A kind of integration granular pattern immobilised enzymes biosensor and its preparation method and application
CN109078176A (en) * 2018-08-14 2018-12-25 武汉大学 The nano material and the preparation method and application thereof of tumor cell membrane cladding
CN111253581A (en) * 2020-01-19 2020-06-09 浙江大学 Metal organic framework material for enhancing combination of chemical power therapy and hunger therapy, preparation method and application
CN111450270A (en) * 2020-04-24 2020-07-28 西南大学 Construction and application of catalytic nanoparticles based on glucose oxidase/iron phosphate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LIU SI‐YANG, XU YUZHI, YANG HUIHUI, LIU LIPING, ZHAO MEITING, YIN WEN, XU YAN‐TONG, HUANG YING, TAN CHAOLIANG, DAI ZONG, ZHANG HUA: "Ultrathin 2D Copper(I) 1,2,4‐Triazolate Coordination Polymer Nanosheets for Efficient and Selective Gene Silencing and Photodynamic Therapy", ADVANCED MATERIALS, VCH PUBLISHERS, DE, vol. 33, no. 18, 1 May 2021 (2021-05-01), DE , XP093077060, ISSN: 0935-9648, DOI: 10.1002/adma.202100849 *
ZENG LELI, HUANG KAI, WAN YILIN, ZHANG JING, YAO XIKUANG, JIANG CHAO, LIN JING, HUANG PENG: "Programmable starving-photodynamic synergistic cancer therapy", SCIENCE CHINA MATERIALS, vol. 63, no. 4, 1 April 2020 (2020-04-01), pages 611 - 619, XP093077056, ISSN: 2095-8226, DOI: 10.1007/s40843-019-1226-8 *
ZHANG JIE-PENG, LIN YAN-YONG, HUANG XIAO-CHUN, CHEN XIAO-MING: "Copper(I) 1,2,4-Triazolates and Related Complexes: Studies of the Solvothermal Ligand Reactions, Network Topologies, and Photoluminescence Properties", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, vol. 127, no. 15, 1 April 2005 (2005-04-01), pages 5495 - 5506, XP093077064, ISSN: 0002-7863, DOI: 10.1021/ja042222t *

Also Published As

Publication number Publication date
CN114452385A (en) 2022-05-10
CN115381944A (en) 2022-11-25

Similar Documents

Publication Publication Date Title
Feng et al. Spherical mesoporous Fe-NC single-atom nanozyme for photothermal and catalytic synergistic antibacterial therapy
CN111253581A (en) Metal organic framework material for enhancing combination of chemical power therapy and hunger therapy, preparation method and application
Zeng et al. Biocatalytic cascade in tumor microenvironment with a Fe2O3/Au hybrid nanozyme for synergistic treatment of triple negative breast cancer
Zhao et al. Advanced nanotechnology for hypoxia-associated antitumor therapy
CN110251480B (en) Silk fibroin/manganese dioxide composite microsphere drug carrier with core-shell structure and preparation method thereof
Shao et al. Cascade catalytic nanoplatform based on “butterfly effect” for enhanced immunotherapy
CN111450270A (en) Construction and application of catalytic nanoparticles based on glucose oxidase/iron phosphate
CN112807430A (en) Application of nano enzyme-based material
CN107242996B (en) A kind of gel rubber material and preparation method thereof for oncotherapy
CN112717147A (en) Preparation method and application of Fe and Pt double-active-site single-atom diagnosis and treatment agent
Gu et al. Dual catalytic cascaded nanoplatform for photo/chemodynamic/starvation synergistic therapy
Wang et al. MnO2 decorated ZIF-8@ GOx for synergistic chemodynamic and starvation therapy of cancer
CN113493223A (en) Preparation method and application of hollow manganese dioxide nanospheres
CN113941009B (en) Metal organic framework nano-carrier and preparation method and application thereof
Li et al. Construction and characterization of magnetic cascade metal-organic framework/enzyme hybrid nanoreactors with enhanced effect on killing cancer cells
Ge et al. Na2S2O4@ Co-metal organic framework (ZIF-67)@ glucose oxidase for biofilm-infecting wound healing with immune activation
WO2023130514A1 (en) Coordination polymer nano material having combined photodynamic-starvation therapy function, preparation method therefor and application thereof
Ozsoy et al. Activities of gallic acid and Fe doped, and glucose oxidase or gold modified ZIF-8 based drug delivery systems in triple negative breast cancer
CN112546227A (en) Preparation method of AIPH bismuth selenide loaded nanoparticles wrapped by calcium manganese phosphide
CN112741903A (en) DNA/nano compound and preparation method and application thereof
Zhang et al. Dual source-powered multifunctional Pt/FePc@ Mn-MOF spindle-like Janus nanomotors for active CT imaging-guided synergistic photothermal/chemodynamic therapy
Song et al. Functionalized nanozyme with drug loading for enhanced tumour combination treatment of catalytic therapy and chemotherapy
Zhang et al. Hollow Mesoporous Molybdenum Single-Atom Nanozyme-Based Reactor for Enhanced Cascade Catalytic Antibacterial Therapy
Gao et al. A general carbon dot-based platform for intracellular delivery of proteins
Wu et al. A hyperthermia-enhanced nanocatalyst based on asymmetric Au@ polypyrrole for synergistic cancer Fenton/photothermal therapy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22917982

Country of ref document: EP

Kind code of ref document: A1